Return on Invested Capital (ROIC): 19.56%
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 19.56% is 17% above its 5-year average of 16.77%, near the high end of its 5-year range (12.60%–19.56%).
As of Friday, June 26, 2026. 4.80% above its 12-month average of 18.66%.
RMD Return on Invested Capital (ROIC) Chart
Annual fiscal-year return on invested capital; no daily interpolation.
RMD Average Return on Invested Capital (ROIC) Chart
RMD Current vs Average Return on Invested Capital (ROIC) Chart
RMD Return on Invested Capital (ROIC) Metrics
RETURN ON INVESTED CAPITAL (ROIC)
19.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
18.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
17.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
16.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
15.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
14.46%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
13.10%
CURRENT VS TTM AVG
+4.80%
CURRENT VS 3Y AVG
+10.31%
CURRENT VS 5Y AVG
+16.64%
CURRENT VS 10Y AVG
+29.33%
CURRENT VS 15Y AVG
+35.23%
CURRENT VS 20Y AVG
+49.27%
RMD Competitors' Return on Invested Capital (ROIC)
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ResMed Inc. (RMD) | $28.81B | 19.56% | 18.66% | 17.73% | 16.77% |
| DexCom, Inc. (DXCM)vs › | $26.82B | 16.61% | 13.40% | 11.07% | 9.62% |
| Moderna, Inc. (MRNA)vs › | $26.45B | -29.70% | -31.12% | -12.69% | 0.19% |
| Biogen Inc. (BIIB)vs › | $31.51B | 6.62% | 7.71% | 8.64% | 10.90% |
| IQVIA Holdings Inc. (IQV)vs › | $31.58B | 8.23% | 8.41% | 8.23% | 6.99% |
| Veeva Systems Inc. (VEEV)vs › | $25.68B | 9.48% | 9.25% | 9.54% | 11.31% |
| Medline Inc. (MDLN)vs › | $31.94B | 5.69% | 6.03% | 3.95% | 3.95% |
| Zoetis Inc. (ZTS)vs › | $32.06B | 21.54% | 21.87% | 20.30% | 19.27% |
| Centene Corp. (CNC)vs › | $32.31B | -13.41% | -4.17% | -0.53% | 0.76% |
| Mettler-Toledo International Inc. (MTD)vs › | $25.24B | 35.46% | 38.26% | 37.51% | 36.01% |
Capital Efficiency
ROIC
19.6%
ROE
23.4%
Return on Invested Capital (ROIC) Formula & Definition
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Return on Invested Capital (ROIC) FAQ
- What is the return on invested capital (ROIC) for ResMed Inc. (RMD)?
- The return on invested capital (ROIC) for RMD stock is 19.56%.
- Is ResMed Inc.'s return on invested capital (ROIC) high or low?
- The return on invested capital (ROIC) of 19.56% is 17% above its 5-year average of 16.77%, near the high end of its 5-year range (12.60%–19.56%).
- What is the TTM average return on invested capital (ROIC) for ResMed Inc. (RMD)?
- The TTM average return on invested capital (ROIC) for RMD stock is 18.66%.
- What is the 3Y average return on invested capital (ROIC) for ResMed Inc. (RMD)?
- The 3Y average return on invested capital (ROIC) for RMD stock is 17.73%.
- What is the 5Y average return on invested capital (ROIC) for ResMed Inc. (RMD)?
- The 5Y average return on invested capital (ROIC) for RMD stock is 16.77%.
- What is the 10Y average return on invested capital (ROIC) for ResMed Inc. (RMD)?
- The 10Y average return on invested capital (ROIC) for RMD stock is 15.12%.
- What is the 15Y average return on invested capital (ROIC) for ResMed Inc. (RMD)?
- The 15Y average return on invested capital (ROIC) for RMD stock is 14.46%.
- What is the 20Y average return on invested capital (ROIC) for ResMed Inc. (RMD)?
- The 20Y average return on invested capital (ROIC) for RMD stock is 13.10%.
RMD Return on Invested Capital (ROIC) History
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-06-30 | 19.56% |
| 2024-06-30 | 17.77% |
| 2023-06-30 | 15.31% |
| 2022-06-30 | 18.29% |
| 2021-06-30 | 12.60% |
| 2020-06-30 | 17.09% |
| 2019-06-30 | 12.68% |
| 2018-06-30 | 12.79% |
| 2017-06-30 | 11.20% |
| 2016-06-30 | 11.78% |
| 2015-06-30 | 17.30% |
| 2014-06-30 | 15.51% |
| 2013-06-30 | 14.61% |
| 2012-06-30 | 11.99% |
| 2011-06-30 | 10.72% |
| 2010-06-30 | 12.22% |
| 2009-06-30 | 10.58% |
| 2008-06-30 | 7.95% |
| 2007-06-30 | 5.66% |
| 2006-06-30 | 9.83% |
| 2005-06-30 | 9.73% |
| 2004-06-30 | 11.82% |
| 2003-06-30 | 11.20% |
| 2002-06-30 | -10.74% |
| 2001-06-30 | 4.36% |
| 2000-06-30 | 22.94% |
| 1999-06-30 | 23.09% |
| 1998-06-30 | 22.33% |
| 1997-06-30 | 12.41% |
| 1996-06-30 | 6.28% |
Related Metrics
About ResMed Inc.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael J. Farrell